Top Markets
#1 0G 0G +39.62%
#2 Axelar Axelar +30.23%
#3 Full Moon Full Moon +30.02%
#4 VVS Finance VVS Finance +29.65%
#5 Fake World Assets Fake World Assets +23.15%
#6 StonkBroker StonkBroker +20.53%
#7 Zora Zora +19.40%
#8 Notcoin Notcoin +17.98%
#9 Merlin's Seal BTC Merlin's Seal BTC +16.13%
#10 ADO Protocol ADO Protocol +15.50%
Coin of the day
0G 0G
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Rang in Aktien #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Aktienkurs
$8.46
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$514.33M
Veränderung (1 Tag)
-2.08%
Veränderung (1 Jahr)
128.03%
Land
US
Handel Kyverna Therapeutics, Inc. (KYTX)

Kategorie

Healthcare
Preis KYTX mit Marktkapitalisierung von B
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
KYTX
$8.46
Marktkapitalisierung von Kyverna Therapeutics, Inc.(KYTX)
Marktkapitalisierung: $514.33M
Mit Stand August 2026 hat Kyverna Therapeutics, Inc. eine Marktkapitalisierung von $514.33M. Das macht Kyverna Therapeutics, Inc. laut unseren Daten zum 13175th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Kyverna Therapeutics, Inc. von 2024 bis 2026
KYTX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für KYTX Vermögenswert B Marktkapitalisierung von B Ergebnisse
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$86,583.59 $514.33M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.264T +1,023,346.70%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$77,329.71 $514.33M
Apple Inc. Apple Inc.
AAPL
$4.701T +913,962.73%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$68,708.99 $514.33M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +812,063.03%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$62,791.15 $514.33M
Microsoft Corporation Microsoft Corporation
MSFT
$3.817T +742,112.15%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$47,147.41 $514.33M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.866T +557,198.01%